NASDAQ
581.05USD
-6.70 (-1.14%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
16.2B
P/E
—
EPS
—
Beta
1.15
52W range
373-677.9
Day range
576.41–590.00
Open
588.00
Prev close
587.75
Volume
51.5K
Avg volume
378.2K
Dividend
0.00
IPO
2016-08-11
https://www.zacks.com/stock/news/2970084/is-medp-worth-buying-as-growth-collides-with-a-premium-valuation?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2970084 · 8/6/2026+0.60
https://www.zacks.com/stock/news/2961393/3-reasons-why-growth-investors-shouldn-t-overlook-medpace-medp?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_11_growth-2961393 · 7/27/2026+0.90
https://www.gurufocus.com/news/8928766/is-it-too-late-to-buy-medpace-holdings-inc-medp-after-39-rally-gf-value-says-undervalued · 6/23/2026+0.40
https://www.newsfilecorp.com/release/300434/INVESTOR-DEADLINE-Stellantis-N.V.-STLA-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Investor-Class-Action-Lawsuit · 6/8/2026-0.50
https://www.newsfilecorp.com/release/300435/INVESTOR-DEADLINE-Medpace-Holdings-Inc.-MEDP-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit · 6/8/2026-1.00
https://www.newsfilecorp.com/release/300359/ROSEN-RECOGNIZED-INVESTOR-COUNSEL-Encourages-Veritone-Inc.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-VERI · 6/6/2026-0.80
https://www.prnewswire.com/news-releases/calx-investors-have-opportunity-to-lead-calix-inc-securities-fraud-lawsuit-302791870.html · 6/4/2026-0.50
https://www.newsfilecorp.com/release/299480/ROSEN-A-LEADING-LAW-FIRM-Encourages-Futu-Holdings-Limited-Investors-to-Inquire-About-Securities-Class-Action-Investigation-FUTU · 5/29/2026-0.80
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-up-fintech-holding-limited-investors-to-inquire-about-securities-class-action-investigation--tigr-302782546.html · 5/27/2026-0.80
https://www.newsfilecorp.com/release/298428/SES-SHAREHOLDER-ACTION-REMINDER-Faruqi-Faruqi-LLP-Reminds-SES-AI-Corporation-SES-Investors-of-Securities-Class-Action-Deadline-on-June-26-2026 · 5/23/2026-0.80
https://www.newsfilecorp.com/release/298426/POET-SHAREHOLDER-ACTION-REMINDER-Faruqi-Faruqi-LLP-Reminds-POET-Technologies-POET-Investors-of-Securities-Class-Action-Deadline-on-June-29-2026 · 5/23/2026-0.50
https://www.prnewswire.com/news-releases/plnt-stock-drop-planet-fitness-stock-plummets-31-amid-low-membership-growth-triggering-securities-fraud-investigation-302768972.html · 5/12/2026-0.80
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
